Playback speed
10 seconds
Is There a Better Lung Immunotherapy Biomarker than PD-L1?
By
Beacon Medical Interchange
FEATURING
Jack West
By
Beacon Medical Interchange
FEATURING
Jack West
0 views
November 2, 2018
Dr. Jack West reviews provocative biomarker results on the IMpower150 trial that tested atezolizumab with ...
read more ↘ carboplatin/paclitaxel +/- bevacizumab & revealed strongest benefit of ate in those with T effector gene signature high expression or high PD-L1.
↖ read less
read more ↘ carboplatin/paclitaxel +/- bevacizumab & revealed strongest benefit of ate in those with T effector gene signature high expression or high PD-L1.
↖ read less
Comments 0
Login to view comments.
Click here to Login
Lung